Jun. 14 at 8:28 AM
$HALB We know that HALB is involved in two large scale trials: a 100-patient 90 day LDN/LDX FDA-safety study for patients with dialysis borne neuropathy etc AND a large-animal trial testing the Tri-Ax nasal spray to treat TBI. I called several people at institutions to calculate the costs for setting up these large scale trials. It’s difficult, but for LDN/LDX and the hardware involved (through ATP) it’s something between
$1.5 million -
$2 million. The animal trials at MSU are more difficult to calculate, but roughly between
$1 million -
$2 million. Let’s say
$3 million all together. IF (!) the 32.5 million shares that were issued recently are for an investor (share purchase agreement), HALB should have sold those shares for .10 minimum, in order to be able to move forward. Food for thought. No need to react.
